Trial Profile
Safety and Tolerability of Herpes Zoster Vaccine in Patients With Rheumatoid Arthritis Immunized Prior to Biologics and Tofacitinib Therapy Initiation
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Feb 2022
Price :
$35
*
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Herpes zoster
- Focus Adverse reactions
- 18 Feb 2020 Planned End Date changed from 1 May 2019 to 1 Jul 2020.
- 18 Feb 2020 Status changed from recruiting to active, no longer recruiting.
- 06 Jan 2020 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified January 2018).